Search Results - "Clynes, R."

Refine Results
  1. 1

    An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis by Jabbari, A., Sansaricq, F., Cerise, J., Chen, J.C., Bitterman, A., Ulerio, G., Borbon, J., Clynes, R., Christiano, A.M., Mackay-Wiggan, J.

    Published in Journal of investigative dermatology (01-07-2018)
    “…Alopecia areata (AA) is a common autoimmune disease with a lifetime risk of ∼2%. In AA, the immune system targets the hair follicle, resulting in clinical hair…”
    Get full text
    Journal Article
  2. 2

    A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk by Redondo, Maria J, Geyer, Susan, Steck, Andrea K, Sharp, Seth, Wentworth, John M, Weedon, Michael N, Antinozzi, Peter, Sosenko, Jay, Atkinson, Mark, Pugliese, Alberto, Oram, Richard A

    Published in Diabetes care (01-09-2018)
    “…We tested the ability of a type 1 diabetes (T1D) genetic risk score (GRS) to predict progression of islet autoimmunity and T1D in at-risk individuals. We…”
    Get full text
    Journal Article
  3. 3
  4. 4

    DIVERGENT ROLES FOR Fc RECEPTORS AND COMPLEMENT IN VIVO by Ravetch, Jeffrey V, Clynes, Raphael A

    Published in Annual review of immunology (01-01-1998)
    “…Recent results obtained in mice deficient in either FcRs or complement have revealed distinct functions for these two classes of molecules. While each is…”
    Get full text
    Journal Article
  5. 5

    Immunoglobulin G-mediated inflammatory responses develop normally in complement-deficient mice by Sylvestre, D, Clynes, R, Ma, M, Warren, H, Carroll, M C, Ravetch, J V

    Published in The Journal of experimental medicine (01-12-1996)
    “…The role of complement in immunoglobulin G-triggered inflammation was studied in mice genetically deficient in complement components C3 and C4. Using the…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

    Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA1c in New-Onset Type 1 Diabetes by Haller, Michael J., Schatz, Desmond A., Skyler, Jay S., Krischer, Jeffrey P., Bundy, Brian N., Miller, Jessica L., Atkinson, Mark A., Becker, Dorothy J., Baidal, David, DiMeglio, Linda A., Gitelman, Stephen E., Goland, Robin, Gottlieb, Peter A., Herold, Kevan C., Marks, Jennifer B., Moran, Antoinette, Rodriguez, Henry, Russell, William, Wilson, Darrell M., Greenbaum, Carla J., Greenbaum, C., Atkinson, M., Baidal, D., Battaglia, M., Becker, D., Bingley, P., Bosi, E., Buckner, J., Clements, M., Colman, P., DiMeglio, L., Evans-Molina, C., Gitelman, S., Goland, R., Gottlieb, P., Herold, K., Knip, M., Krischer, J., Lernmark, A., Moore, W., Moran, A., Muir, A., Palmer, J., Peakman, M., Philipson, L., Raskin, P., Redondo, M., Rodriguez, H., Russell, W., Spain, L., Schatz, D.A., Sosenko, J., Wherrett, D., Wilson, D., Winter, W., Ziegler, A., Anderson, M., Antinozzi, P., Benoist, C., Blum, J., Bourcier, K., Chase, P., Clare-Salzler, M., Clynes, R., Cowie, C., Eisenbarth, G., Fathman, C.G., Grave, G., Harrison, L., Hering, B., Insel, R., Jordan, S., Kaufman, F., Kay, T., Kenyon, N., Klines, R., Lachin, J., Leschek, E., Mahon, J., Marks, J.B., Monzavi, R., Nanto-Salonen, K., Nepom, G., Orban, T., Parkman, R., Pescovitz, M., Peyman, J., Pugliese, A., Ridge, J., Roep, B., Roncarolo, M., Savage, P., Simell, O., Sherwin, R., Siegelman, M., Skyler, J.S., Steck, A., Thomas, J., Trucco, M., Wagner, J.

    Published in Diabetes care (01-09-2018)
    “…OBJECTIVE A pilot study suggested that combination therapy with low-dose anti-thymocyte globulin (ATG) and pegylated granulocyte colony-stimulating factor…”
    Get full text
    Journal Article
  11. 11

    Effect of Oral Insulin on Prevention of Diabetes in Relatives of Patients With Type 1 Diabetes: A Randomized Clinical Trial by Krischer, Jeffrey P, Schatz, Desmond A, Bundy, Brian, Skyler, Jay S, Greenbaum, Carla J

    “…IMPORTANCE: Type 1 diabetes requires major lifestyle changes and carries increased morbidity and mortality. Prevention or delay of diabetes would have major…”
    Get full text
    Journal Article
  12. 12

    Immune complexes as therapy for autoimmunity by Clynes, Raphael

    Published in The Journal of clinical investigation (01-01-2005)
    “…For several decades, intravenous Ig has been used as treatment for a variety of immune-related diseases, including immune thrombocytopenic purpura (ITP),…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20